These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28592286)

  • 21. Integrating innovative therapeutic strategies into the management of renal cell carcinoma.
    Dutcher JP; Mourad WF; Ennis RD
    Oncology (Williston Park); 2012 Jun; 26(6):526-30, 532, 534. PubMed ID: 22870536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
    Demaria S; Guha C; Schoenfeld J; Morris Z; Monjazeb A; Sikora A; Crittenden M; Shiao S; Khleif S; Gupta S; Formenti SC; Vikram B; Coleman CN; Ahmed MM
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Priming of the Tumor Microenvironment by Radiation.
    Jiang W; Chan CK; Weissman IL; Kim BYS; Hahn SM
    Trends Cancer; 2016 Nov; 2(11):638-645. PubMed ID: 28741502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.
    Sharabi AB; Tran PT; Lim M; Drake CG; Deweese TL
    Oncology (Williston Park); 2015 May; 29(5):331-40. PubMed ID: 25979541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.
    Marciscano AE; Haimovitz-Friedman A; Lee P; Tran PT; Tomé WA; Guha C; Spring Kong FM; Sahgal A; El Naqa I; Rimner A; Marks LB; Formenti SC; DeWeese TL
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):35-52. PubMed ID: 30836168
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer immunotherapy using tumor cryoablation.
    Sidana A
    Immunotherapy; 2014; 6(1):85-93. PubMed ID: 24341887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation versus cryoablation for atrioventricular nodal re-entrant tachycardia in children: a value comparison.
    Oster ME; Yang Z; Stewart-Huey K; Glanville M; Porter A; Campbell R; Webb B; Strieper M
    Cardiol Young; 2017 Mar; 27(2):224-228. PubMed ID: 27087499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical immune interventions for solid malignancies.
    Zeltsman M; Mayor M; Jones DR; Adusumilli PS
    Am J Surg; 2016 Oct; 212(4):682-690.e5. PubMed ID: 27659157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells.
    Kim SJ; Ha GH; Kim SH; Kang CD
    Immunol Invest; 2014; 43(6):517-34. PubMed ID: 24295450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial to Radiation in Multimodal Tumor Immune Therapies-Mechanisms and Application.
    Frey B; Gaipl US
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer immunotherapy: how low-level ionizing radiation can play a key role.
    Janiak MK; Wincenciak M; Cheda A; Nowosielska EM; Calabrese EJ
    Cancer Immunol Immunother; 2017 Jul; 66(7):819-832. PubMed ID: 28361232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy.
    Regen-Tuero HC; Ward RC; Sikov WM; Littrup PJ
    Radiol Imaging Cancer; 2021 Mar; 3(2):e200134. PubMed ID: 33817653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations.
    Xu W; Zhang X; Hu X; Zhiyi C; Huang P
    Cancer Lett; 2019 Sep; 460():86-95. PubMed ID: 31254552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
    Walshaw RC; Honeychurch J; Illidge TM
    Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy with radiotherapy in urological malignancies.
    Mehta S; Illidge T; Choudhury A
    Curr Opin Urol; 2016 Nov; 26(6):514-22. PubMed ID: 27552139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
    Dhupkar P; Gordon N
    Adv Exp Med Biol; 2017; 995():33-51. PubMed ID: 28321811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.
    Chen L; Sun J; Yang X
    Cancer Lett; 2016 Jan; 370(1):78-84. PubMed ID: 26472630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy and radiotherapy].
    Bockel S; Antoni D; Deutsch É; Mornex F
    Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cancer, radiotherapy and immune system].
    Nesseler JP; Peiffert D; Vogin G; Nickers P
    Cancer Radiother; 2017 Jun; 21(4):307-315. PubMed ID: 28501459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.